Skip to main content
OpenTrials
Completed

NCT Number: NCT01384929

Study of Intensive Care Units in India

There is scant data on the casemix and practices in Indian intensive care units (ICUs). Most of the available data comes from single centre studies. There is a dire need to have data from Indian ICUs to reflect the vast spectrum of critical care illness, services and practices. INDICAPS planned to collect data of all patients in the ICU on one particular day, and four such days spread throughout a one-year period were selected: the second Wednesday of July and October this year, i.e. July 14 and October 13, 2010 and the second Wednesday of January and April next year, i.e. January 12 and April 13, 2011. As many ICUs all over the country as possible were asked to participate. The investigators aimed to gather information about ICUs, patients in ICUs, the types and severity of illness, monitoring and therapeutic modalities used, types of infections,mortality rates, etc.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Tata Memorial Hospital

Mumbai, Maharashtra, 400058, India

About this study

The following information will be analysed:

Case-mix, severity of illness, prevalence of infection, hemodynamic monitoring and therapy, mechanical ventilation practices, nutrition and outcome

  • Seasonal and regional variations in the above
  • Epidemiology and variations in antibiotic use
  • Patterns of microorganisms and outcome
  • Prevalence and outcome of specific tropical febrile illnesses, including malaria, dengue fever, leptospirosis, scrub typhus
  • Prevalence and outcome of toxins and poisonings
  • Relation of ICU and hospital organizational issues to prevalence of infection and outcome
  • Organisation of intensive care services
  • End of life - Ethical decisions

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients present in the ICU July 14, 2010, October 13, 2010, January 12, 2011 and April 13, 2011

Treatment and study plan

Primary outcomes

  1. All cause mortality

    Time frame: 30-days

Secondary outcomes

  1. ICU Length of stay

    Time frame: 30 days

    Stay in ICU till 30 days

  2. Hospital length of stay

    Time frame: 30 days

    Stay in hospital till 30 days

  3. Hospital survival

    Time frame: 30 days

    Survival at hospital discharge or at 30 days

Sponsors and collaborators

Lead sponsor

Indian Society of Critical Care Medicine

Other

Registry information

Official study title

Indian Intensive Care Case Mix and Practice Patterns Study

Acronym: INDICAPS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jun 29, 2011
Registry last updated
Jun 29, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.